Medication-related Osteonecrosis of the Jaw
📧 Sign up to get email alerts when something new happens for Medication-related Osteonecrosis of the Jaw.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Comparing Implant Retention Versus Removal for MRONJ at Implant Sites [NA]
Clinical trial update comparing implant retention versus removal at sites affected by medication-related osteonecrosis of the jaw (MRONJ); c…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®) [NA]
This entry reports a clinical trial investigating Regenfast®, a polynucleotides-hyaluronic acid hydrogel, for medication-related osteonecros…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management [Phase 2]
Phase 2 clinical trial evaluating human amniotic membrane for the management of stage II medication-related osteonecrosis of the jaw is curr…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) [Phase 3]
Phase 3 trial update noting ongoing enrollment by invitation for Pentoxifylline and Tocopherol (PENTO) in medication-related osteonecrosis o…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Therapeutic Exposures and Risk Factors in MRONJ
A clinical trial studying therapeutic exposures and risk factors for medication-related osteonecrosis of the jaw, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Immunological Parameters Between MRONJ Stages
A Marmara University-led clinical trial is recruiting to study immunological parameters across stages of medication-related osteonecrosis of…